316 related articles for article (PubMed ID: 10146907)
1. Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.
Holliday SM; Faulds D
Pharmacoeconomics; 1994 Feb; 5(2):141-71. PubMed ID: 10146907
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus: where do we stand and what is the next step for eradication?
Komatsu H
World J Gastroenterol; 2014 Jul; 20(27):8998-9016. PubMed ID: 25083074
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
Harris A; Yong K; Kermode M
Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
[TBL] [Abstract][Full Text] [Related]
6. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
8. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
9. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
Zurn P; Danthine JP
Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
[TBL] [Abstract][Full Text] [Related]
10. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
Szucs TD; Smala A; Berger K; Windorfer A
Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
[TBL] [Abstract][Full Text] [Related]
11. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
12. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
13. Global programme for control of hepatitis B infection.
Kane M
Vaccine; 1995; 13 Suppl 1():S47-9. PubMed ID: 7571830
[TBL] [Abstract][Full Text] [Related]
14. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
15. [Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China].
Yang PC; Zhang SX; Sun PP; Cai YL; Lin Y; Zou YH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):845-851. PubMed ID: 28738454
[No Abstract] [Full Text] [Related]
16. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
[TBL] [Abstract][Full Text] [Related]
17. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.
Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P
Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840
[TBL] [Abstract][Full Text] [Related]
18. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
[TBL] [Abstract][Full Text] [Related]
20. Impact of hepatitis B virus infection on women and children.
Shapiro CN; Margolis HS
Infect Dis Clin North Am; 1992 Mar; 6(1):75-96. PubMed ID: 1533649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
